Clinical Trials Logo

EBV Infection clinical trials

View clinical trials related to EBV Infection.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06075927 Not yet recruiting - Clinical trials for Stem Cell Transplant

Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT

Start date: November 1, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

To evaluate the safety and tolerability of partial HLA-matched VSTs against both CMV and EBV viruses in recipients of allogeneic hematopoietic stem cells with refractory viral infections (CMV and/or EBV). Preliminary evaluation of the efficacy of partial HLA-matched VSTs against both CMV and EBV viruses in recipients of allogeneic hematopoietic stem cells with refractory viral infections (CMV and/or EBV); To monitor the duration and expansion of multi-virus VSTs cells after infusion.

NCT ID: NCT04690036 Not yet recruiting - Transplant Clinical Trials

PD-1 Antibody for Reactive EBV After BMT

Start date: July 1, 2021
Phase: Early Phase 1
Study type: Interventional

PD-1 antibody for reactivation of EBV after transplantation in patients with CAEBV/EBV-HLH